Plasma proteomic profiling one year post-delivery of women with pre-eclampsia
Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Elite
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Plasma
SUBMITTER: 
Antigoni Manousopoulou
LAB HEAD: Spiros D. Garbis
PROVIDER: PXD009325 | Pride | 2020-05-26
REPOSITORIES: Pride
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| 22FEB18_PE_PLASMA_TMT_31.raw | Raw | |||
| 22FEB18_PE_PLASMA_TMT_32.raw | Raw | |||
| 22FEB18_PE_PLASMA_TMT_33.raw | Raw | |||
| 22FEB18_PE_PLASMA_TMT_34.raw | Raw | |||
| 22FEB18_PE_PLASMA_TMT_35.raw | Raw |
Items per page: 5 1 - 5 of 71 |
Publications
Increased plasma CD14 levels 1 year postpartum in women with pre-eclampsia during pregnancy: a case-control plasma proteomics study.
Manousopoulou Antigoni A Abad Fatma S FS Garay-Baquero Diana J DJ Birch Brian R BR van Rijn Bas B BB Lwaleed Bashir A BA Garbis Spiros D SD
Nutrition & diabetes 20200114 1
Epidemiological data suggest that pre-eclampsia (PE) is associated with an increased risk of post-delivery metabolic dysregulation. The aim of the present case-control observational study was to examine the global plasma proteomic profile 1 year postpartum in women who developed PE during pregnancy (n = 5) compared to controls (n = 5), in order to identify a novel predictive marker linking PE with long-term metabolic imbalance. Key findings were verified with enzyme-linked immunosorbent assay (E ...[more]
Similar Datasets
Project description:Pre-eclampsia is one of the most serious pregnancy-associated disorders, and is defined by hypertension (systolic blood pressure higher than 140mmHg or diastolic blood pressure higher than 90mmHg) with proteinuria (more than 0.3g/day). It is not a simple complication of pregnancy, but is rather a syndrome of multiple organ failure involving the liver, kidney, and lung, as well as coagulatory and neural systems. There is now an emerging consensus that pre-eclampsia is a complex polygenetic trait in which maternal and fetal genes, as well as environmental factors, are involved, although the precise mechanism of the disorder has remained elusive. In this study, we have performed gene expression profiling to further elucidate the mechanisms underlying the development of the pre-eclamptic condition. We thus compared the expression profiles in placentas from women who underwent a normal pregnancy and from women suffering from severe pre-eclampsia. In addition, we compared the expression data between the early and late onset forms of pre-eclampsia and obtained a number of potential new prognostic biomarkers for this disease. Experiment Overall Design: Placental biopsies were obtained during Caesarean section from both normotensive patients and from those with pre-eclampsia (n = 14) (early onset type; earlier than 31 weeks gestation, n = 6 and late onset type; 31 weeks gestation or later, n = 8). Pre-eclampsia was defined as a blood pressure of higher than 160/110 mmHg, with proteinuria of more than 2g in a 24 hour collection. The expression profiles of approximately 47,669 genes were analyzed using a Whole Human Genome Oligo Microarray Kit (Agilent Technologies). A total of 10 placentas from women with pre-eclampsia and four from normal subjects were used in the hybridizations. Reverse transcription labeling and hybridization was performed using the protocol recommended by the manufacturer. The microarray experiments were then carried out using competitive hybridization experiments with Cy3 and Cy5-labeled targets; one with test placental RNAs from patients or normal control subjects, and another using pooled normal placental RNA as a template control for normalization. The glass slides were scanned using an Agilent G2565BA microarray scanner. Scanned images were then analyzed using Feature Extraction software. The average signal intensities were corrected for median background intensity and transferred with GenBank descriptors to a Microsoft Excel data spreadsheet (Microsoft, Redmond, WA). Data analysis was performed using Genespring software version 6.1 (Silicon Genetics, Redwood City, CA). After intensity dependent normalization (Lowess), the expression levels relative to the control were calculated as a ratio, and the expression profiles were then compared between each pre-eclamptic or normal sample.
2008-05-07 | E-GEOD-4707 | biostudies-arrayexpress
Project description:Genome-wide DNA methylation analysis of COVID-19 severity using the Illumina HumanMethylationEPIC microarray platform to analyze over 850,000 methylation sites, comparing COVID-19 patients during and one year after infection, using whole blood tissue.
2022-02-23 | GSE197152 | GEO
Project description:Genome wide placental DNA methylation profiling of full term and preterm deliveries sampled from 5 full term deliveries and 4 preterm deliveries. The Illumina HumanMethylation450 Beadchip was used to obtain DNA methylation profiles across approximately 485,577 CpGs in formalin fixed samples. Samples included 4 placental tissues from 4 women with preterm delivery and 5 placental tissues from 5 women with full term delivery. 9 women's placental DNA (4 women had perterm deliveries and 5 women had full term deliveries) were hybridised to the Illumina HumanMethylation450 Beadchip
2016-07-25 | E-GEOD-49504 | biostudies-arrayexpress
Project description:Lausannevirus one year genome evolution in allopatric versus sympatric conditions
| PRJEB20258 | ENA
Project description:Introduction. Factors contributing to kidney transplant fibrosis remain incompletely understood—particularly in the absence of acute complications. Methods. Baseline and one-year surveillance biopsies from 15 uncomplicated living donor kidney transplants were subjected to microarray and quantitative RT-PCR (qRT-PCR) analyses in order to examine changes in gene expression patterns over time. Biopsy pairs were purposefully selected from allografts with no history of acute complications and were divided into those that were histologically normal (n = 7) and those that had developed subclinical interstitial fibrosis (n = 8) at 1 year. Results. Compared to the paired baseline specimens, expression levels of 3578 probesets were found altered in all the one-year biopsies studied. A large proportion of the upregulated genes in this transplant-associated profile were functionally linked with inflammation, immunity or response to injury. These included components of inflammation-related signaling pathways (integrin, interferon and TLR) as well as individual mediators of inflammatory and immune responses. An additional 2884 probesets demonstrated altered expression in fibrotic grafts only at 1 year. The gene products in this fibrosis-associated profile were also predominantly linked with inflammation and immune function, suggesting exaggerated inflammatory activity within the fibrotic grafts. qRT-PCR analyses confirmed the predicted expression patterns for selected transcripts from the microarray profiles. Conclusions. Transcriptional profiles of histologically normal living donor renal allografts indicate that there is ongoing injury response and inflammation at 1 year compared to the immediate post-transplant period. Subclinical development of interstitial fibrosis during the first post-transplant year is associated with additional upregulation of inflammation-related genes. Keywords: time course, comparative expression
2007-03-30 | GSE7392 | GEO
Project description:For women identified as at risk for preterm birth attributable to a sonographic short cervix, the determination of imminent delivery is crucial for patient management. The current study aimed to identify amniotic fluid proteins that could predict imminent delivery in asymptomatic patients with a short cervix. An aptamer-based multiplex platform was used to profile 1,310 AF proteins, and the significance of protein dysregulation was determined by moderated t-tests between women who destined to deliver within two weeks of amnicentesis. The area under the receiver operating characteristic curve was calculated to determine whether protein abundance in combination with cervical length improved the prediction of imminent delivery after amnicentesis as compared to cervical length alone.
2022-09-26 | GSE186135 | GEO
Project description:We investigated ecotoxicological effects and toxicogenomic responses in fathead minnows (Pimephales promelas) exposed to an environmentally-relevant concentration (0.83 mg/L) of the munitions compound cyclotrimethylenetrinitramine (RDX) in one year and multi-generational assays. In the one year assay, RDX effects were discerned by comparing breeding groups reared in control or RDX-exposure conditions for one year. RDX had no detectable effect on gonad-somatic index, or condition factor in females assayed at 1 day and at 1, 3, 6, 9, and 12 months, however the liver-somatic index was significantly increased versus controls only at the 12 month time point. RDX had no effect on live-prey capture rates at all time points assayed and no significant impacts on egg production, fertilization or hatch success in the 1-year exposure trial. Genomic analyses indicated that RDX exposure caused limited differential expression of transcripts within time points and no functional conservation of effects indicative of RDX exposure among time points for either brain or liver tissues in the one year exposure. In the multi-generational assay, the effects of acute (96h) exposure to RDX were compared in fish reared to the F2 generation in either control or RDX-exposure conditions. The RDX-reared fish were not observed to have appreciably enhanced RDX tolerance versus the control-reared fish. However, significant differences in gene expression were observed among the control and RDX-reared fish related to neuro-excitatory glutamate metabolism, sensory signaling and processes in neurological development. In total, our results indicate that exposure to an RDX concentration approximating maximum levels observed in the field (0.83 mg/L) caused limited impacts in fathead minnows in a one year exposure, however caused altered expression in genes involved in neural function in a multi-generational exposure.
2010-07-30 | GSE21100 | GEO
Project description:We investigated ecotoxicological effects and toxicogenomic responses in fathead minnows (Pimephales promelas) exposed to an environmentally-relevant concentration (0.83 mg/L) of the munitions compound cyclotrimethylenetrinitramine (RDX) in one year and multi-generational assays. In the one year assay, RDX effects were discerned by comparing breeding groups reared in control or RDX-exposure conditions for one year. RDX had no detectable effect on gonad-somatic index, or condition factor in females assayed at 1 day and at 1, 3, 6, 9, and 12 months, however the liver-somatic index was significantly increased versus controls only at the 12 month time point. RDX had no effect on live-prey capture rates at all time points assayed and no significant impacts on egg production, fertilization or hatch success in the 1-year exposure trial. Genomic analyses indicated that RDX exposure caused limited differential expression of transcripts within time points and no functional conservation of effects indicative of RDX exposure among time points for either brain or liver tissues in the one year exposure. In the multi-generational assay, the effects of acute (96h) exposure to RDX were compared in fish reared to the F2 generation in either control or RDX-exposure conditions. The RDX-reared fish were not observed to have appreciably enhanced RDX tolerance versus the control-reared fish. However, significant differences in gene expression were observed among the control and RDX-reared fish related to neuro-excitatory glutamate metabolism, sensory signaling and processes in neurological development. In total, our results indicate that exposure to an RDX concentration approximating maximum levels observed in the field (0.83 mg/L) caused limited impacts in fathead minnows in a one year exposure, however caused altered expression in genes involved in neural function in a multi-generational exposure.
2010-07-30 | GSE21101 | GEO
Project description:Here we propose a pilot project to examine the contribution of lipid mediators and lipidomics to preterm delivery among obese women. Preterm delivery is one of the top causes of infant morbidity and mortality. Our specific interests are in understanding risks of preterm delivery among obese women, and in particular the contribution of the inflammatory response to early preterm delivery (<32 weeks) among obese women. The inflammatory response is a known contributor to preterm delivery, and obesity is associated with inflammation and an increased risk of early preterm delivery, but the distinct contribution of aberrations in the inflammatory response to preterm delivery among obese women has not been examined previously. Most previous studies of preterm delivery and the inflammatory response have examined one or only a few of its components at once, primarily cytokines, and a few studies have examined dyslipidemia. We propose to extend these types of investigations by examining lipid mediators and conducting global lipid profiling. Lipid mediators are key regulators of inflammation and include fatty acids and their oxygenated bioactive metabolites such as oxylipins (e.g., prostaglandins, HETEs or hydroxyeicosatetraenoic acids, and other eicosanoids), ceramides and sphingoid bases including sphingosine-1-phosphate. Examination of lipid mediators and lipid profiling is particularly relevant to understanding distinct risks among obese women, given the known inter-relatedness of obesity, dyslipidemia, and inflammation. Our overarching hypothesis is that the inflammatory response impacts risk of preterm delivery and that its impact is distinct among obese versus non-obese women. Here we propose a pilot project that compares mid-pregnancy measurements of lipid mediators and lipid profiling among obese pregnant women. Findings from this pilot will provide critical preliminary data to inform larger-scope grant proposals that will comprehensively address our overarching hypothesis. Specifically, we will examine mid-pregnancy lipid mediators in obese women who deliver preterm compared to those who deliver at term. In addition, we will use untargeted global profiling of complex lipids to determine whether obese women who deliver preterm have a distinct lipidomic signature, relative to obese women who deliver at term. We propose a nested case-control study that utilizes maternal mid-pregnancy (15-20 weeks gestation) serum samples from a biobank that represents over one million deliveries in California from 2007-2012. We propose to examine 50 obese women who delivered preterm and 50 who delivered at term. This will provide adequate preliminary data for a larger-scale grant proposal.
2017-07-20 | ST000811 | MetabolomicsWorkbench
Project description:Here we propose a pilot project to examine the contribution of lipid mediators and lipidomics to preterm delivery among obese women. Preterm delivery is one of the top causes of infant morbidity and mortality. Our specific interests are in understanding risks of preterm delivery among obese women, and in particular the contribution of the inflammatory response to early preterm delivery (<32 weeks) among obese women. The inflammatory response is a known contributor to preterm delivery, and obesity is associated with inflammation and an increased risk of early preterm delivery, but the distinct contribution of aberrations in the inflammatory response to preterm delivery among obese women has not been examined previously. Most previous studies of preterm delivery and the inflammatory response have examined one or only a few of its components at once, primarily cytokines, and a few studies have examined dyslipidemia. We propose to extend these types of investigations by examining lipid mediators and conducting global lipid profiling. Lipid mediators are key regulators of inflammation and include fatty acids and their oxygenated bioactive metabolites such as oxylipins (e.g., prostaglandins, HETEs or hydroxyeicosatetraenoic acids, and other eicosanoids), ceramides and sphingoid bases including sphingosine-1-phosphate. Examination of lipid mediators and lipid profiling is particularly relevant to understanding distinct risks among obese women, given the known inter-relatedness of obesity, dyslipidemia, and inflammation. Our overarching hypothesis is that the inflammatory response impacts risk of preterm delivery and that its impact is distinct among obese versus non-obese women. Here we propose a pilot project that compares mid-pregnancy measurements of lipid mediators and lipid profiling among obese pregnant women. Findings from this pilot will provide critical preliminary data to inform larger-scope grant proposals that will comprehensively address our overarching hypothesis. Specifically, we will examine mid-pregnancy lipid mediators in obese women who deliver preterm compared to those who deliver at term. In addition, we will use untargeted global profiling of complex lipids to determine whether obese women who deliver preterm have a distinct lipidomic signature, relative to obese women who deliver at term. We propose a nested case-control study that utilizes maternal mid-pregnancy (15-20 weeks gestation) serum samples from a biobank that represents over one million deliveries in California from 2007-2012. We propose to examine 50 obese women who delivered preterm and 50 who delivered at term. This will provide adequate preliminary data for a larger-scale grant proposal.
2017-07-20 | ST000810 | MetabolomicsWorkbench